AilseBio

Alceus

This company develops a platform that uses artificial intelligence to design therapeutic proteins and program immune cells for clinicians and researchers treating solid tumours.

TenSixty Bio

The company develops an artificial intelligence platform to discover tumor-selective epitopes and create antibody-based therapeutics for healthcare providers and oncology patients.

Asylia Diagnostics

This company develops an artificial intelligence platform to identify biomarkers and drug targets for precision immunotherapy for pharmaceutical and diagnostic firms.

Baseimmune

The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.

Alp Bio

This company develops a hybrid platform combining human immune organoids and artificial intelligence to assess immunogenicity risks for biotechnology and pharmaceutical drug developers.

Mnemo Therapeutics

This biotechnology company develops cell therapies and an epigenetic antigen discovery platform to treat solid tumours and blood cancers for healthcare providers.

Genevation

This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.

Sift Bio

The company develops a peptide immunotherapy platform that uses artificial intelligence to identify microbial analogs for treating solid tumours in cancer patients.